Affiliation: University of Pennsylvania
- Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulinStanley S Schwartz
Diabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USA
Diabetes Metab Syndr Obes 3:243-52. 2010..Thiazolidinediones represent an effective tool for targeting some features of this increased risk as they decrease insulin resistance and can prevent and/or delay diabetes progression...
- Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapiesStanley Schwartz
Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Diabetes Metab Syndr Obes 3:227-42. 2010....
- Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatideStanley Schwartz
University of Pennsylvania, Philadelphia, PA, USA
Curr Med Res Opin 24:3009-22. 2008....
- Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetesLuis H Eraso
Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Diabetes Care 33:408-10. 2010..Fetuin-A is an inhibitor of vascular calcification and a mediator of insulin resistance. This study evaluated the association of plasma fetuin-A and peripheral arterial disease (PAD)...
- One-year weight losses in the Look AHEAD study: factors associated with successThomas A Wadden
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Obesity (Silver Spring) 17:713-22. 2009..The lifestyle intervention was clinically effective in all subsets of an ethnically and demographically diverse population...
- Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitusJay D Amsterdam
Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 3309, USA
Neuropsychobiology 54:208-14. 2006..We examined the safety and efficacy of s-citalopram therapy in patients with co-morbid depression and diabetes, and its ability to improve glycemic control...
- Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial resultsHoward C Herrmann
Hospital of the University of Pennsylvania, Philadelphia, 19104, USA
J Sex Med 3:303-8. 2006..Erectile dysfunction (ED) may be one manifestation of a generalized vascular disorder characterized by endothelial dysfunction. Statin drugs may improve endothelial function, even before altering the lipid profile...
- Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitusNehal N Mehta
Cardiovascular Institute, Philadelphia, Pennsylvania, USA
Am J Cardiol 107:406-11. 2011....
- How to manage perioperative endocrine insufficiencyBenjamin A Kohl
Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, 3400 Spruce Street, Dulles Building, Suite 680, Philadelphia, PA 19104, USA
Anesthesiol Clin 28:139-55. 2010..This article focuses on the 4 most commonly encountered endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Specific challenges pertaining to patients with pheochromocytoma are also discussed...
- Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whitesSeth S Martin
Cardiovascular Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Diabetes 58:1887-92. 2009..We investigated the hypothesis that apoB is a superior marker of CAC relative to LDL cholesterol...
- Surgery in the patient with endocrine dysfunctionBenjamin A Kohl
Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Med Clin North Am 93:1031-47. 2009..This article focuses on 4 of the most common endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Perioperative challenges in patients presenting with pheochromocytoma are also discussed...
- Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!Stanley Schwartz
Main Line Health System, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Diabetes Care 36:2107-11. 2013..Schwartz and DeFronzo's contribution, Drs. Umpierrez and Korytkowski provide a defense of insulin in the inpatient setting as the unquestioned gold standard for glycemic management in hospitalized settings...
- The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretinsStanley Schwartz
Main Line Health System, University of Pennsylvania, Philadelphia, PA, USA
Curr Diab Rep 14:466. 2014..We strongly urge randomized prospective controlled studies to test our proposal and we offer a process of care to facilitate this research and their use in our hospitalized patients...
- Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?Struan F A Grant
Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Endocr Rev 31:183-93. 2010..In this review, we address recent advances in the genetics of T1D and T2D and how such discoveries have in turn shed some light on the genetics of LADA as being potentially at the "genetic intersection" of these two major diseases...